Correction: Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier (Molecular Neurodegeneration, (2023), 18, 1, (7), 10.1186/s13024-023-00597-5)

Kassandra Kisler; Abhay P. Sagare; Divna Lazic; Sam Bazzi; Erica Lawson; Ching Ju Hsu; Yaoming Wang; Anita Ramanathan; Amy R. Nelson; Zhen Zhao; Berislav V. Zlokovic

ArticleOPEN ACCESS

Correction: Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier (Molecular Neurodegeneration, (2023), 18, 1, (7), 10.1186/s13024-023-00597-5)

Kisler K
Sagare A
Lazic D
et al.

Molecular Neurodegeneration

DOI: 10.1186/s13024-023-00606-7

0Citations

15Readers

Get full text

Abstract

The original article [1] contained an obsolete version of Additional File 5: Fig. S5 which has since been amended.

Cite

CITATION STYLE

APA

Kisler, K., Sagare, A. P., Lazic, D., Bazzi, S., Lawson, E., Hsu, C. J., … Zlokovic, B. V. (2023, December 1). Correction: Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier (Molecular Neurodegeneration, (2023), 18, 1, (7), 10.1186/s13024-023-00597-5). Molecular Neurodegeneration. BioMed Central Ltd. https://doi.org/10.1186/s13024-023-00606-7

Correction: Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier (Molecular Neurodegeneration, (2023), 18, 1, (7), 10.1186/s13024-023-00597-5)

Abstract

Cite

Register to see more suggestions